RU2010123029A - CHEMICAL PRODUCT FOR THE RADIATORY REMOVAL OF BENEFICIAL PATHOLOGICAL CHANGES AND THE METHOD OF ITS APPLICATION ON THE SKIN OF THE FACE, HEAD AND BODY - Google Patents

CHEMICAL PRODUCT FOR THE RADIATORY REMOVAL OF BENEFICIAL PATHOLOGICAL CHANGES AND THE METHOD OF ITS APPLICATION ON THE SKIN OF THE FACE, HEAD AND BODY Download PDF

Info

Publication number
RU2010123029A
RU2010123029A RU2010123029/15A RU2010123029A RU2010123029A RU 2010123029 A RU2010123029 A RU 2010123029A RU 2010123029/15 A RU2010123029/15 A RU 2010123029/15A RU 2010123029 A RU2010123029 A RU 2010123029A RU 2010123029 A RU2010123029 A RU 2010123029A
Authority
RU
Russia
Prior art keywords
benign
skin
change
pathological changes
capillary
Prior art date
Application number
RU2010123029/15A
Other languages
Russian (ru)
Inventor
Гойко ДУНКИЦ (RS)
Гойко ДУНКИЦ
Натаса ДЖОРДЖЕВИЦ (RS)
Натаса ДЖОРДЖЕВИЦ
Александар ДУНКИЦ (RS)
Александар ДУНКИЦ
Original Assignee
Гойко ДУНКИЦ (RS)
Гойко ДУНКИЦ
Натаса ДЖОРДЖЕВИЦ (RS)
Натаса ДЖОРДЖЕВИЦ
Александар ДУНКИЦ (RS)
Александар ДУНКИЦ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гойко ДУНКИЦ (RS), Гойко ДУНКИЦ, Натаса ДЖОРДЖЕВИЦ (RS), Натаса ДЖОРДЖЕВИЦ, Александар ДУНКИЦ (RS), Александар ДУНКИЦ filed Critical Гойко ДУНКИЦ (RS)
Publication of RU2010123029A publication Critical patent/RU2010123029A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

1. Химический препарат для постепенного удаления доброкачественных патологических изменений кожи лица, головы и тела, который включает синергетическую смесь следующего химического состава: 19,40-40,74% уксусной кислоты, 3,15-7,43% азотной кислоты, 0,93-4,00% нитрата серебра, 0,93-1,96% салициловой кислоты, 0-2,8% Mg2+, 0-2,3% Cu2+, 0-2,7% Fe3+, 0,5-6,2% диметилглоксима, 0,3-17,2% трихлоруксусной кислоты и 19,63-56,78% дистиллированной воды. ! 2. Обеспечение препарата состава по п.1, где препарат для постепенного удаления доброкачественных патологических изменений помещен в капилляр и наносится с применением капилляра точно в количестве, находящемся в пределах 1·10-6 см3 и 3·10-2 см3, на доброкачественное изменение, подлежащее удалению, посредством размещения более узкого конца стеклянного капилляра на поверхность доброкачественного изменения, что приводит к разрушению клеток обработанного изменения, и процесс разрушения доброкачественного изменения проявляется в обесцвечивании обработанного участка, при этом обработанный участок не должен подвергаться воздействию воды на протяжении следующих 72 ч, и тогда корка является образованием, которое остается на месте до завершения эпителизации новой кожи, после чего корка отпадет самопроизвольно, и цвет новой кожи станет через время таким же, как цвет окружающей кожи. 1. A chemical preparation for the gradual removal of benign pathological changes in the skin of the face, head and body, which includes a synergistic mixture of the following chemical composition: 19.40-40.74% acetic acid, 3.15-7.43% nitric acid, 0.93 -4.00% silver nitrate, 0.93-1.96% salicylic acid, 0-2.8% Mg2 +, 0-2.3% Cu2 +, 0-2.7% Fe3 +, 0.5-6.2 % dimethylgloxim, 0.3-17.2% trichloroacetic acid and 19.63-56.78% distilled water. ! 2. The provision of the drug composition according to claim 1, where the drug for the gradual removal of benign pathological changes is placed in the capillary and applied using the capillary exactly in an amount in the range of 1 · 10-6 cm3 and 3 · 10-2 cm3 for a benign change to be removed by placing the narrower end of the glass capillary on the surface of the benign change, which leads to the destruction of the cells of the treated change, and the process of destruction of the benign change is manifested in discoloration and the treated area, while the treated area should not be exposed to water for the next 72 hours, and then the peel is the formation that remains in place until the epithelization of the new skin is completed, after which the peel will fall off spontaneously, and the color of the new skin will become the same after a while like the color of the surrounding skin.

Claims (2)

1. Химический препарат для постепенного удаления доброкачественных патологических изменений кожи лица, головы и тела, который включает синергетическую смесь следующего химического состава: 19,40-40,74% уксусной кислоты, 3,15-7,43% азотной кислоты, 0,93-4,00% нитрата серебра, 0,93-1,96% салициловой кислоты, 0-2,8% Mg2+, 0-2,3% Cu2+, 0-2,7% Fe3+, 0,5-6,2% диметилглоксима, 0,3-17,2% трихлоруксусной кислоты и 19,63-56,78% дистиллированной воды.1. A chemical preparation for the gradual removal of benign pathological changes in the skin of the face, head and body, which includes a synergistic mixture of the following chemical composition: 19.40-40.74% acetic acid, 3.15-7.43% nitric acid, 0.93 -4.00% silver nitrate, 0.93-1.96% salicylic acid, 0-2.8% Mg 2+ , 0-2.3% Cu 2+ , 0-2.7% Fe 3+ , 0 5-6.2% dimethylgloxim, 0.3-17.2% trichloroacetic acid and 19.63-56.78% distilled water. 2. Обеспечение препарата состава по п.1, где препарат для постепенного удаления доброкачественных патологических изменений помещен в капилляр и наносится с применением капилляра точно в количестве, находящемся в пределах 1·10-6 см3 и 3·10-2 см3, на доброкачественное изменение, подлежащее удалению, посредством размещения более узкого конца стеклянного капилляра на поверхность доброкачественного изменения, что приводит к разрушению клеток обработанного изменения, и процесс разрушения доброкачественного изменения проявляется в обесцвечивании обработанного участка, при этом обработанный участок не должен подвергаться воздействию воды на протяжении следующих 72 ч, и тогда корка является образованием, которое остается на месте до завершения эпителизации новой кожи, после чего корка отпадет самопроизвольно, и цвет новой кожи станет через время таким же, как цвет окружающей кожи. 2. The provision of the drug composition according to claim 1, where the drug for the gradual removal of benign pathological changes is placed in the capillary and applied using the capillary exactly in the amount in the range of 1 · 10 -6 cm 3 and 3 · 10 -2 cm 3 , a benign change to be removed by placing the narrower end of the glass capillary on the surface of the benign change, which leads to the destruction of the cells of the treated change, and the process of destruction of the benign change appears to be discolored the treated area, while the treated area should not be exposed to water for the next 72 hours, and then the peel is a formation that remains in place until the epithelization of the new skin is completed, after which the peel will fall off spontaneously, and the color of the new skin will become the same over time like the color of the surrounding skin.
RU2010123029/15A 2007-11-07 2008-10-20 CHEMICAL PRODUCT FOR THE RADIATORY REMOVAL OF BENEFICIAL PATHOLOGICAL CHANGES AND THE METHOD OF ITS APPLICATION ON THE SKIN OF THE FACE, HEAD AND BODY RU2010123029A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RSP-2007/0438 2007-11-07
RS20070438A RS52576B (en) 2007-11-07 2007-11-07 Chemical preparation for gradual removal of benign lesions and procedure for its application on facial, head and body skin

Publications (1)

Publication Number Publication Date
RU2010123029A true RU2010123029A (en) 2011-12-20

Family

ID=40291186

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010123029/15A RU2010123029A (en) 2007-11-07 2008-10-20 CHEMICAL PRODUCT FOR THE RADIATORY REMOVAL OF BENEFICIAL PATHOLOGICAL CHANGES AND THE METHOD OF ITS APPLICATION ON THE SKIN OF THE FACE, HEAD AND BODY

Country Status (3)

Country Link
RS (1) RS52576B (en)
RU (1) RU2010123029A (en)
WO (1) WO2009061228A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110898076A (en) * 2019-12-12 2020-03-24 刘贤贤 Medicine for removing cutin and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2760901A (en) * 1952-11-12 1956-08-28 Marvin D Steinberg Method for removing verrucae
US4588590A (en) * 1981-12-21 1986-05-13 Jaye-Boern Laboratories, Inc. Method of treating keratosis and compositions useful therefor
WO1994012194A1 (en) * 1992-12-03 1994-06-09 Schering-Plough Healthcare Products, Inc. Compositions for treating corns, calluses and warts comprising salicylic acid and lanthanide
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions

Also Published As

Publication number Publication date
WO2009061228A1 (en) 2009-05-14
RS20070438A (en) 2008-08-07
RS52576B (en) 2013-04-30

Similar Documents

Publication Publication Date Title
RU2012148821A (en) METHOD FOR PRODUCING ZINC INSULIN COMPLEXES
ATE395052T1 (en) USE OF C-KIT INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES
EP2481726A3 (en) Crystal forms of saxagliptin and processes for preparing same
DE602005009585D1 (en) A new process for the preparation and a novel crystal form of the agomelatine and pharmaceutical compositions containing them
RU2010120700A (en) POROUS CARBON COMPOSITE MATERIALS AND THE METHOD FOR PRODUCING THEM, AND ALSO ADSORBENTS, COSMETIC PRODUCTS, CLEANING PRODUCTS AND COMPOSITE PHOTOCATALYTIC MATERIALS CONTAINING THEM
DE60314298D1 (en) THERAPEUTIC PLASTER WITH CAPSAICIN-CONTAINING POLYSILOXAN MATRIX
EP1803803A3 (en) Cleaning compounds and method and system for using the cleaning compound
RU2011145054A (en) CRYSTAL FORMS OF SAXAGLIPTIN
RU2009118942A (en) METHOD FOR STIMULATING TISSUE REGENERATION
DE60001346D1 (en) Process for the production of Form II crystals of clarithromycin
ATE447336T1 (en) METHOD FOR REMOVAL OF NITRIC ACID FROM AN AQUEOUS LIQUID AND METHOD FOR PRODUCING BEVERAGES
RU2010123029A (en) CHEMICAL PRODUCT FOR THE RADIATORY REMOVAL OF BENEFICIAL PATHOLOGICAL CHANGES AND THE METHOD OF ITS APPLICATION ON THE SKIN OF THE FACE, HEAD AND BODY
DE60110185D1 (en) Composition and method for parenteral administration of ibuprofen D, L-, or L-lysinate
RU2015129097A (en) PLASTIC FOR TREATMENT OF DISEASES OF THE CENTURY CONTAINING KLOBETAZOLE
EA200601471A1 (en) CELL CELL PROLIFERATION INHIBITORS (OPTIONS), PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHOD OF DESTROYING CANCER CELLS (VARIANTS) AND METHOD OF TREATMENT AND PREVENTION OF MALANCES AND PREVENTION OF HUMAN MEDICINES
DE602006008335D1 (en) NOVEL METHOD FOR THE PRODUCTION OF QUATERNIC ACID AND AMMONIUM SALTS
CN203247167U (en) Combined type water purifier
Kanchana et al. Effect of fluoride on the crystallization and spectral properties of cholesterol
CN102919924A (en) Preparation method for ginger juice drink
CN102038918A (en) Retained fluid prescription for treating cold and preparation method thereof
RU2006116681A (en) METHOD FOR TROPHIC ULCER TREATMENT AND MEANS FOR ITS IMPLEMENTATION
CN102038724A (en) Formula of baste for treating baldness and preparation method thereof
CN203238134U (en) Combined type magnetized water purifier
RU2008116389A (en) METHOD FOR PREPARING ULTRA-FRESH WATER ENRICHED WITH H + HYDROGEN IONS
CN206447653U (en) A kind of three-dimensional pasture and water frame of culturing pool water body purification